Hsbc Holdings PLC Pfizer Inc Call Options Transaction History

Hsbc Holdings PLC

$145 Billion
Q1 2024

Call Options

26 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $13.2 Million - $15.1 Million	-508,600 Reduced 75.23%	167,500 $4.65 Million
Q4 2023 Feb 12, 2024	BUY	$26.13 - $33.94 $3.1 Million - $4.03 Million	118,600 Added 21.27%	676,100 $19.5 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $12.3 Million - $14.4 Million	383,900 Added 221.14%	557,500 $18.5 Million
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $924,671 - $1.07 Million	-25,600 Reduced 12.85%	173,600 $6.37 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $1.58 Million - $2.06 Million	-40,200 Reduced 16.79%	199,200 $8.13 Million

Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $6.53 Million - $8.52 Million	156,400 Added 188.43%	239,400 $12.3 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $2.14 Million - $2.62 Million	-49,000 Reduced 37.12%	83,000 $3.63 Million
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $535,095 - $634,455	-11,500 Reduced 8.01%	132,000 $6.72 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $4.7 Million - $5.83 Million	-102,800 Reduced 41.74%	143,500 $7.43 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $859,456 - $1.27 Million	20,800 Added 9.22%	246,300 $14.5 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $2.16 Million - $2.77 Million	-55,000 Reduced 19.61%	225,500 $9.83 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $4.54 Million - $5.14 Million	-126,400 Reduced 31.06%	280,500 $11 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $3.12 Million - $3.52 Million	93,200 Added 29.71%	406,900 $14.7 Million
Q4 2020 Feb 25, 2021	BUY	$33.47 - $42.56 $8.93 Million - $11.4 Million	266,800 Added 568.87%	313,700 $11.5 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $1.2 Million - $1.41 Million	37,900 Added 421.11%	46,900 $1.72 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $7.32 Million - $8.88 Million	-242,900 Reduced 96.43%	9,000 $294,000
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $8.92 Million - $11.6 Million	-274,600 Reduced 52.16%	251,900 $9.05 Million
Q2 2019 Aug 13, 2019	BUY	$36.98 - $41.52 $12.5 Million - $14 Million	337,300 Added 178.28%	526,500 $22.8 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $15.3 Million - $16.9 Million	-409,300 Reduced 68.39%	189,200 $8.04 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $10.7 Million - $12.3 Million	279,300 Added 87.5%	598,500 $26.1 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $5.69 Million - $6.9 Million	165,100 Added 107.14%	319,200 $14.1 Million
Q2 2018 Aug 10, 2018	SELL	$32.98 - $35.16 $164,899 - $175,799	-5,000 Reduced 3.14%	154,100 $5.59 Million
Q1 2018 May 11, 2018	BUY	$31.91 - $37.02 $3.86 Million - $4.48 Million	121,100 Added 318.68%	159,100 $5.64 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $16.6 Million - $17.6 Million	-499,800 Reduced 92.93%	38,000 $1.38 Million
Q3 2017 Nov 14, 2017	SELL	$31.0 - $34.15 $14.5 Million - $16 Million	-467,600 Reduced 46.51%	537,800 $19.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,005,400	1,005,400 $33.8 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

Vanguard Group Inc Valley Forge, PA

507M
Shares

$14.2 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

431M
Shares

$12.1 Billion
0.28% of portfolio
State Street Corp Boston, MA

291M
Shares

$8.13 Billion
0.37% of portfolio
Wellington Management Group LLP Boston, MA

178M
Shares

$4.97 Billion
0.89% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

122M
Shares

$3.42 Billion
0.79% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account